Neugalin XR Tablet 82.5 mg contains Pregabalin Extended Release (XR), a modified-release formulation designed to provide sustained therapeutic effects over an extended period. Pregabalin is a well-established antiepileptic and neuromodulatory agent that works by binding to voltage-gated calcium channels in the central nervous system. This action reduces the release of excitatory neurotransmitters, thereby calming overactive nerves and decreasing abnormal pain signals.

The XR (extended-release) technology allows the medication to be released gradually throughout the day, ensuring consistent blood levels and prolonged symptom control. Compared to immediate-release formulations, Neugalin XR 82.5 mg offers the convenience of once-daily dosing, which may improve patient compliance and maintain steady relief from neuropathic pain.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Neugalin XR Tablet 82.5 mg is indicated for:

• Neuropathic pain associated with diabetic peripheral neuropathy

• Post-herpetic neuralgia (nerve pain following shingles)

• Other chronic nerve-related pain conditions, as prescribed by a physician

The extended-release formulation is particularly suitable for patients who require stable, long-lasting pain control throughout the day and night.

Dosage and Administration

• Adults: Typically taken once daily after an evening meal, or as directed by a healthcare professional.

• The tablet should be swallowed whole with water and must not be crushed, chewed, or split, as this may interfere with the extended-release mechanism.

• Dosage may be adjusted based on treatment response, tolerability, and kidney function.

For patients switching from immediate-release Pregabalin to extended-release tablets, physicians will determine the equivalent dose to maintain effective symptom control.

Abrupt discontinuation is not recommended. The dose should be tapered gradually under medical supervision to prevent withdrawal symptoms or worsening of the condition.

Precautions and Warnings

• Contraindicated in patients with known hypersensitivity to Pregabalin.

• Use cautiously in individuals with renal impairment; dose adjustments may be necessary.

• May cause dizziness, drowsiness, or blurred vision; avoid driving or operating heavy machinery until the effect is known.

• Alcohol and other central nervous system depressants may increase sedative effects.

• Monitor for mood changes, depression, or suicidal thoughts during therapy.

Side Effects

Common side effects may include:

• Dizziness or drowsiness

• Headache

• Blurred vision

• Weight gain or increased appetite

• Peripheral edema (swelling of hands or feet)

• Dry mouth or constipation

Most side effects are mild to moderate and often improve with continued use. Seek immediate medical attention if severe allergic reactions, breathing difficulty, or significant mood changes occur.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

Store below 30°C in a cool, dry place, protected from light and moisture. Keep out of reach of children.

Neugalin XR Tablet 82.5 mg (Pregabalin Extended Release) provides convenient, once-daily, sustained relief from neuropathic pain. Its advanced formulation ensures steady symptom control, improved patient adherence, and enhanced quality of life under proper medical supervision.